GB2454672A — Chromogenic protease substrates
Assigned to Mologic Ltd · Expires 2009-05-20 · 17y expired
What this patent protects
A polypeptide comprising a chromogenic amino acid, wherein the chromogenic amino acid is flanked by at least one amino acid to the N- and C-termini, and wherein the amine group of the chromogenic amio acid has a pKa of less than 5, and the amino acid is capable of reacting with a…
USPTO Abstract
A polypeptide comprising a chromogenic amino acid, wherein the chromogenic amino acid is flanked by at least one amino acid to the N- and C-termini, and wherein the amine group of the chromogenic amio acid has a pKa of less than 5, and the amino acid is capable of reacting with a conjugated aldehyde. The chromogenic amino acid may be p-aminobenzoic acid (pABA). A method of detecting a protease using such a polypeptide comprising: cleaving the polypeptide with a protease to create a fragment containing the chromogenic amino acid, reacting a conjugated aldehyde with the fragment to produce a coloured adduct and detecting the coloured adduct, the presence of the coloured adduct being indicative of the protease. A method of making such a polypeptide by synthesising an amino acid dimer comprising one chromogenic amino acid and incorporating the dimer into the remainder of the polypeptide. Also claimed is a synthetic polypeptide comprising at least one chromogenic amino acid.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.